March 2015
Features
Real-life Story of the 'Bionic Eye,' the Argus II
A real-life experience with the only retinal prosthesis approved by the FDA and Health Canada.
RVO Workup: When it's Necessary and What to Order
A review of the risk factors and differential diagnosis.
How to Manage a Migrating Dexamethasone Intravitreal Implant
What migration means and how it can impact vision.
Lessons from DRCR.net Protocol T
What we can take from the study and apply in our clinics.
Departments
Clinical Trial Closeup
A Quick Look at CHROMA, SPECTRI
Lead investigator provides details on parallel trials of lampalizumab.
Coding Commentary
OCT and FP: Why can’t I bill both?
New guidance from CMS describes why and the few times when you can.
Editor's Page
Innovation Insight
Selecting Patients for the Iluvien Implant
Sustained-release device emerges after a decade-long journey.
Literature Review
Can Anti-VEGF Cause GA in Wet AMD?
A host of trials are trying to answer this question. Here’s what they’ve found so far.
News
Retina CEO
Paying for Drugs When the Bill Is Due
Cash forecasting can help manage those high-limit credit cards.
Retina Fellows Forum
What’s the Cause of this Panuveitis?
Sensitivity to light, pain and blurry vision persisted for two weeks.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
